Two Sigma Investments
ODT

Two Sigma Investments’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Two Sigma Investments’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-170,888
Closed -$231K – 5017
2021
Q4 		$231K Buy
170,888
+131,075
+329% +$310K ﹤0.01% 3825
2021
Q3 		$116K Sell
39,813
-350,771
-90% -$1.17M ﹤0.01% 4069
2021
Q2 		$1.36M Sell
390,584
-258,935
-40% -$889K ﹤0.01% 2208
2021
Q1 		$2.22M Buy
649,519
+298,491
+85% +$5.64M 0.01% 1620
2020
Q4 		$6.74M Buy
351,028
+37,257
+12% +$575K 0.02% 772
2020
Q3 		$4.21M Buy
+313,771
New +$8.89M 0.02% 882
2020
Q1 		– Sell
-19,322
Closed -$627K – 4184
2019
Q4 		$627K Sell
19,322
-40,159
-68% -$1.24M ﹤0.01% 2607
2019
Q3 		$1.55M Buy
+59,481
New +$1.99M 0.01% 1624

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return